Health and Fitness Health and Fitness
Wed, August 4, 2010
Tue, August 3, 2010
[ Tue, Aug 03rd 2010 ] - Market Wire
00 a.m. Eastern Time

AMAG Pharmaceuticals, Inc. to Present at Canaccord Genuity 30th Annual Global Growth Conference


Published on 2010-08-03 13:36:39 - Market Wire
  Print publication without navigation


LEXINGTON, Mass.--([ BUSINESS WIRE ])--AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that management will present an overview of the company at the Canaccord Genuity 30th Annual Global Growth Conference on August 10, 2010 at 9:00 a.m. ET. The conference is being held August 10-12, 2010 in Boston, MA.

A live webcast of the presentation will be accessible through the Investors section of the companya™s website at [ www.amagpharma.com ]. Following the conference, the webcast will be archived on the AMAG Pharmaceuticals, Inc. website for approximately two weeks.

About AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals, Inc. is a biopharmaceutical company that utilizes its proprietary technology for the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease. AMAG manufactures and sells two commercial products, Feraheme® (ferumoxytol) Injection for intravenous (IV) use and GastroMARK®, an oral contrast agent used in magnetic resonance imaging. For additional company information, please visit [ www.amagpharma.com ].

Feraheme is a registered trademark of AMAG Pharmaceuticals, Inc.